Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,024+, returning 12,699.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,699.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,992.96% |
DeFi Development (DFDV) | 2,246.56% |
WW International, Inc Common Stock (WW) | 1,919.85% |
Zepp Health (ZEPP) | 1,811.54% |
Abits (ABTS) | 1,490.09% |
FiEE (FIEE) | 1,171.74% |
Oncology Institute (TOI) | 1,089.54% |
Abivax SA American Depositary Shares (ABVX) | 1,059.12% |
Lizhi (SOGP) | 929.59% |
Global Interactive Technologies (GITS) | 850.21% |
Nova Lifestyle I (NVFY) | 712.41% |
Dominari (DOMH) | 703.48% |
Airnet Technology (ANTE) | 627.88% |
Mobilicom Limited Warrants (MOBBW) | 612.21% |
mF International Limited Ordinary Shares (MFI) | 591% |
Nanobiotix (NBTX) | 559.49% |
Better Home & Finance (BETR) | 557.56% |
ThredUp (TDUP) | 554.86% |
Lixte Biotechnology (LIXTW) | 553.57% |
TMC the metals (TMC) | 550% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 523.69% |
Super X AI Technology Limited - Ordinary Shares (SUPX) | 519.83% |
Eightco (OCTO) | 514.9% |
